Breaking News Instant updates and real-time market news.

GNMK

GenMark

$6.84

-0.16 (-2.29%)

16:15
10/02/18
10/02
16:15
10/02/18
16:15

GenMark announces FDA submission of two ePlex BCID panels

GenMark Diagnostics announced the submission of two additional ePlex Blood Culture Identification Panels - the Gram-Negative Panel and Fungal Pathogen Panel - to the U.S. Food and Drug Administration. These panels, together with the ePlex BCID Gram-Positive Panel previously submitted to the FDA in June 2018, are being developed on the Company's ePlex sample-to-answer system, for the diagnosis and disease management of bloodstream infections that can lead to sepsis. "The submissions of our BCID-GN and BCID-FP panels to the FDA signify our continued commitment to ePlex menu expansion, which is one of GenMark's top priorities. Sepsis is a global healthcare priority and we are confident that our ePlex BCID solution will improve the management of patients with blood stream infections and help combat antibiotic resistance," said Hany Massarany, President and Chief Executive Officer.

  • 03

    Oct

  • 09

    Oct

  • 14

    Nov

GNMK GenMark
$6.84

-0.16 (-2.29%)

11/03/17
RAJA
11/03/17
DOWNGRADE
RAJA
Market Perform
GenMark downgraded to Market Perform from Outperform at Raymond James
Raymond James analyst Nicholas Jansen downgraded GenMark to Market Perform following the negative Q3 report and "sizable" reduction in Q4 guidance. The analyst said the combination of slower-than-anticipated European traction, a shift to more rentals, and delay in the US menu expansion are too much for his "patience to overcome."
11/03/17
ADAM
11/03/17
NO CHANGE
Target $10
ADAM
Buy
GenMark price target lowered to $10 from $14 at Canaccord
Canaccord analyst Mark Massaro lowered his price target on GenMark to $10 from $14 following mixed Q3 results. The analyst also has forecasts well below consensus for Q4, citing lower utilization of ePlex placements in Europe and more of a shift to reagent rentals vs. capital placements. Massaro maintained his Buy rating on GenMark shares as he said his long-term thesis remains intact.
01/08/18
ADAM
01/08/18
NO CHANGE
ADAM
Buy
Week 52 flu data positive for Quidel, GenMark, says Canaccord
Canaccord analyst Mark Massaro said the CDC published its week 52 Influenza Surveillance Report and noted its increase and widespread flu incidence. He is encouraged by the data and now believes there is upside to revenue estimates for both Quidel (QDEL) and GenMark (GNMK). Massaro has a Buy ratings on both stocks, with a $52 price target on Quidel and a $10 price target on GenMark shares.
07/31/18
ADAM
07/31/18
NO CHANGE
Target $10
ADAM
Buy
GenMark Q2 indicates company on track with growth initiatives, says Canaccord
Canaccord analyst Mark Massaro said GenMark delivered solid Q2 results, indicating the company remains on track with its growth initiatives. He said the outlook should help build investor confidence throughout the balance of the year and he continues to believe that a multi-billion dollar opportunity awaits. Massaro reiterated his Buy rating and raised his price target to $10 from $9 on GenMark shares.

TODAY'S FREE FLY STORIES

GOOG

Alphabet

$1,113.91

-4.25 (-0.38%)

, GOOGL

Alphabet Class A

$1,120.60

-5.83 (-0.52%)

06:26
02/21/19
02/21
06:26
02/21/19
06:26
Periodicals
Sen. Warner slams Google for Nest's hidden microphone, Business Insider reports »

Virginia Sen. Mark…

GOOG

Alphabet

$1,113.91

-4.25 (-0.38%)

GOOGL

Alphabet Class A

$1,120.60

-5.83 (-0.52%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Feb

  • 25

    Feb

  • 03

    Mar

  • 18

    Mar

PLAB

Photronics

$11.34

-0.05 (-0.44%)

06:26
02/21/19
02/21
06:26
02/21/19
06:26
Earnings
Photronics reports Q1 EPS 8c, consensus 5c »

Reports Q1 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

TPC

Tutor Perini

$17.72

0.25 (1.43%)

06:25
02/21/19
02/21
06:25
02/21/19
06:25
Hot Stocks
Tutor Perini awarded $253M contract by MTA New York City Transit »

Tutor Perini announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Feb

STNG

Scorpio Tankers

$19.66

-0.28 (-1.40%)

06:24
02/21/19
02/21
06:24
02/21/19
06:24
Conference/Events
Scorpio Tankers management to meet with BTIG »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

DIN

Dine Brands

$88.52

1.08 (1.24%)

06:24
02/21/19
02/21
06:24
02/21/19
06:24
Hot Stocks
Dine Brands board approves 10% increase to quarterly dividend to 69c per share »

The company's board…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

GMDA

Gamida Cell

$13.46

0.01 (0.07%)

06:23
02/21/19
02/21
06:23
02/21/19
06:23
Hot Stocks
Gamida Cell presents new data from NAM-NK and NiCord programs »

Gamida Cell announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

DIN

Dine Brands

$88.52

1.08 (1.24%)

06:22
02/21/19
02/21
06:22
02/21/19
06:22
Earnings
Dine Brands sees FY19 adjusted EPS $6.90-$7.20, consensus $6.93 »

Applebee's domestic…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

LPCN

Lipocine

$1.71

(0.00%)

06:22
02/21/19
02/21
06:22
02/21/19
06:22
Conference/Events
Lipocine management to meet with Roth Capital »

Meeting to be held in San…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

KURA

Kura Oncology

$15.06

-0.22 (-1.44%)

06:22
02/21/19
02/21
06:22
02/21/19
06:22
Conference/Events
Kura Oncology management to meet with Piper Jaffray »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

DIN

Dine Brands

$88.52

1.08 (1.24%)

06:21
02/21/19
02/21
06:21
02/21/19
06:21
Earnings
Dine Brands reports Q4 adjusted EPS $1.70, consensus $1.57 »

Reports Q4 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

JSAIY

J Sainsbury

$0.00

(0.00%)

06:21
02/21/19
02/21
06:21
02/21/19
06:21
Downgrade
J Sainsbury rating change  »

J Sainsbury downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

KNX

Knight-Swift

$34.71

0.475 (1.39%)

06:21
02/21/19
02/21
06:21
02/21/19
06:21
Conference/Events
Knight-Swift management to meet with Stephens »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

KIDS

OrthoPediatrics

$38.34

0.96 (2.57%)

06:21
02/21/19
02/21
06:21
02/21/19
06:21
Conference/Events
OrthoPediatrics management to meet with Piper Jaffray »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

  • 26

    Mar

  • 27

    Mar

GDOT

Green Dot

$74.69

-0.05 (-0.07%)

06:20
02/21/19
02/21
06:20
02/21/19
06:20
Recommendations
Green Dot analyst commentary  »

Green Dot Q4 margin…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LOPE

Grand Canyon

$97.13

0.18 (0.19%)

06:20
02/21/19
02/21
06:20
02/21/19
06:20
Recommendations
Grand Canyon analyst commentary  »

Grand Canyon correction…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

KAI

Kadant

$89.52

1.55 (1.76%)

06:19
02/21/19
02/21
06:19
02/21/19
06:19
Conference/Events
Kadant management to meet with Barrington »

Meeting to be held in St.…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

SCBFF

Standard Chartered

$0.00

(0.00%)

06:19
02/21/19
02/21
06:19
02/21/19
06:19
Periodicals
Standard Chartered earmarks $900M for U.S., UK fines, FT reports »

Standard Chartered has…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PQG

PQ Group

$16.71

0.16 (0.97%)

06:18
02/21/19
02/21
06:18
02/21/19
06:18
Earnings
Breaking Earnings news story on PQ Group »

PQ Group sees FY19…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

PQG

PQ Group

$16.71

0.16 (0.97%)

06:18
02/21/19
02/21
06:18
02/21/19
06:18
Earnings
PQ Group sees FY19 revenue $1.64B-$1.67B, consensus $1.68B »

Sees FY19: Adjusted…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

PQG

PQ Group

$16.71

0.16 (0.97%)

06:16
02/21/19
02/21
06:16
02/21/19
06:16
Earnings
PQ Group reports Q4 adjusted EPS 17c, consensus 13c »

Reports Q4 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

TEF

Telefonica

$8.73

0.07 (0.81%)

, TIGO

Millicom

$60.25

(0.00%)

06:16
02/21/19
02/21
06:16
02/21/19
06:16
Hot Stocks
Millicom buys Telefonica mobile businesses in Central America for $1.65B »

Millicom International…

TEF

Telefonica

$8.73

0.07 (0.81%)

TIGO

Millicom

$60.25

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

  • 25

    Feb

  • 12

    Mar

  • 19

    Mar

  • 19

    Mar

HTGC

Hercules Capital

$13.12

0.07 (0.54%)

06:15
02/21/19
02/21
06:15
02/21/19
06:15
Hot Stocks
Hercules Capital names Seth Meyer as CFO »

Hercules Capital…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

JOUT

Johnson Outdoors

$65.68

-0.23 (-0.35%)

06:15
02/21/19
02/21
06:15
02/21/19
06:15
Conference/Events
Johnson Outdoors management to meet with Oppenheimer »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

  • 22

    Feb

  • 28

    Feb

  • 28

    Feb

CGC

Canopy Growth

$46.18

-0.2 (-0.43%)

06:14
02/21/19
02/21
06:14
02/21/19
06:14
Recommendations
Canopy Growth analyst commentary  »

Piper Jaffray remains…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SAP

SAP

$106.91

0.08 (0.07%)

06:14
02/21/19
02/21
06:14
02/21/19
06:14
Hot Stocks
SAP board recommends FY18 dividend increase of 7% to EUR1.50 per share »

The supervisory board of…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Feb

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.